Acute treatment with corticosteroids decreases IGF-1 and IGF-2 expression in the rat diaphragm and gastrocnemius

American Journal of Respiratory and Critical Care Medicine

Volumn 159, Issue 1, 1999, Pages 283-289

  Gayan Ramirez, Ghislaine ^a   Vanderhoydonc, Frank ^a   Verhoeven, Guido ^a   Decramer, Marc ^a,b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALBICORT; CORTICOSTEROID; METHYLPREDNISOLONE SODIUM SUCCINATE; SOMATOMEDIN B; SOMATOMEDIN C; TRIAMCINOLONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREATHING MUSCLE; CONTROLLED STUDY; DIAPHRAGM MUSCLE; DNA PROBE; DOSE RESPONSE; GASTROCNEMIUS MUSCLE; INTRAMUSCULAR DRUG ADMINISTRATION; LUNG INSUFFICIENCY; MALE; MUSCLE ATROPHY; MUSCLE WEAKNESS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 0032924566     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.159.1.9803021     Document Type: Article

References (40)

1. Nava, S., G. Gayan-Ramirez, H. Rollier, A. Bisschop, R. Dom, V. De Bock, and M. Decramer. 1996. Effects of acute steroid administration on ventilatory and peripheral muscles in rats. Am. J. Respir. Crit. Care Med. 153:1888-1896.
2. Dodson, M. V., R. E. Allen, and K. L. Hossner. 1985. Ovine somatomedin, multiplication-stimulating activity, and insulin promote skeletal muscle satellite cell proliferation in vitro. Endocrinology 117:2357-2363.
3. Vandenburgh, H. H., P. Karlisch, J. Shansky, and R. Feldstein. 1991. Insulin and IGF-I induce pronounced hypertrophy of skeletal myofibers in tissue culture. Am. J. Physiol. 260:C475-C484.
4. DeVol, D. L., P. Rotwein, J. L. Sadow, J. Novakofski, and P. J. Bechtel. 1990. Activation of insulin-like growth factor gene expression during work-induced skeletal muscle growth. Am. J. Physiol. 259:E89-E95.
5. Turner, J. D., P. Rotwein, J. Novakofski, and P. J. Bechtel. 1988. Induction of mRNA for IGF-I and -II during growth hormone-stimulated muscle hypertrophy. Am. J. Physiol. 255:E513-E517.
6. Froesch, E. R., C. Schmid, J. Schwander, and J. Zapf. 1985. Actions of insulin-like growth factors. Ann. Rev. Physiol. 47:443-467.
7. McCusker, R. H., C. Camacho-Hubner, and D. R. Clemmons. 1989. Identification of the types of insulin-like growth factor-binding proteins that are secreted by muscle cells in vitro. J. Biol. Chem. 264: 7795-7800.
8. Adams, G. R., and F. Haddad. 1996. The relationships among IGF-I, DNA content, and protein accumulation during skeletal muscle hypertrophy. J. Appl. Physiol. 81:2509-2516.
9. Peers, K., G. Gayan-Ramirez, R. Lysens, F. Vanderhoydonc, G. Verhoeven, and M. Decramer. 1998. Alterations of IGF mRNA tissue abundance in rat gastroenemius after immobilization and denervation (abstract). Am. J. Respir. Crit. Care Med. 157:A668.
10. Glazner, G. W., A. E. Morrison, and D. N. Ishii. 1994. Elevated insulin-like growth factor (IGF) gene expression in sciatic nerves during IGF-supported nerve regeneration. Brain Res. Mol. Brain Res. 25:265-272.
11. Glazner, G. W., and D. N. Ishii. 1995. Insulin-like growth factor gene expression in rat muscle during reinnervation. Muscle Nerve 18:1433-1442.
12. De Sevilla, L., S. A. McCune, and M. E. White. 1994. Insulin-like growth factor mRNA expression in tissues of lean and obese male SHFF/Mcc-fa(cp) rats. Comp. Biochem. Physiol. Biochem. Mol. Biol. 109:371-382.
13. Furlanetto, R. W., and J. M. Marino. 1987. Radioimmunoassay of somatomedin C/insulin-like growth factor I. Methods Enzymol. 146:216-226.
14. Chirgwin, J. M., A. E. Przybyla, R. J. McDonald, and W. J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294-5299.
15. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Extraction, purification, and analysis of messenger RNA from eukaryotic cells. In C. Nolan, editor. Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory Press, New York, 7.43-7.45.
16. Thoren, M., K. Hall, and T. Rahn. 1981. Somatomedin A levels in patients with Cushing's disease. Acta Endocrinol. 97:12-17.
17. Furlanetto, R. W., L. E. Underwood, J. J. Van Wyk, and A. J. D'Ercole. 1977. Estimation of somatomedin-C in normals and patients with pituitary disease. J. Clin. Invest. 60:648-657.
18. Gourmelen, M., F. Girard, and M. Binoux. 1982. Serum somatomedin/insulin-like growth factor (IGF) and IGF carrier levels in patients with Cushing's syndrome or receiving glucocorticoid therapy. J. Clin. Endocrinol. Metab. 54:885-892.
19. Underwood, L. E., D. R. Clemmons, M. Maes, A. J. D'Ercole, and J. M. Ketelslegers. 1986. Regulation of somatomedin-C/insulin-like growth factor I by nutrients. Hormone Res. 24:166-176.
20. Donahue, S. P., and L. S. Phillips. 1989. Response of IGF-1 to nutritional support in malnourished hospital patients: a possible indicator of short-term changes in nutritional status. Am. J. Clin. Nutr. 50:962-969.
21. Jacob, V., J. E. LeCarpentier, S. Salzano, V. Naylor, G. Wild, C. B. Brown, and A. M. El Nahas. 1990. IGF-I, a marker of undernutrition in hemodialysis patients. Am. J. Clin. Nutr. 52:39-44.
22. Thissen, J. P., L. E. Underwood, D. Maiter, M. Maes, D. R. Clemmons, and J. Ketelslegers. 1991. Failure of insulin-like growth factor-I (IGF-I) infusion to promote growth in protein-restricted rats despite normalization of serum IGF-I concentrations. Endocrinology 128:885-890.
23. Reeves, R. D., L. Dickinson, J. Lee, B. Kilgore, B. Branham, and J. Elders. 1979. Effects of dietary composition on somatomedin activity in growing rats. J. Nutr. 109:613-620.
24. Lewis, M. I., T. J. LoRusso, and M. Fournier. 1997. Effect of insulin-like growth factor I and/or growth hormone on diaphragm of malnourished adolescent rats. J. Appl. Physiol. 82:1064-1070.
25. Phillips, L. S., and T. G. Unterman. 1984. Somatomedin activity in disorders of nutrition and metabolism. Clin. Endocrinol. Metab. 13:145-189.
26. Lanz, J. K., M. Donahoe, R. M. Rogers, and M. Ontell. 1992. Effects of growth hormone on diaphragmatic recovery from malnutrition. J. Appl. Physiol. 73:801-805.
27. Lowe, W. L., M. Adamo, H. Werner, C. T. Roberts, and D. LeRoith. 1989. Regulation by fasting of rat insulin-like growth factor I and its receptor effects on gene expression and binding. J. Clin. Invest. 84: 619-626.
28. Maes, M., Y. Amand, L. E. Underwood, D. Maiter, and J. Ketelslegers. 1988. Decreased serum insulin-like growth factor I response to growth hormone in hypophysectomized rats fed a low protein diet: evidence for a post-receptor defect. Acta Endocrinol. 117:320-326.
29. Lee, W., R. R. Bowsher, J. M. Apathy, M. C. Smith, and D. P. Henry. 1991. Measurement of insulin-like growth factor-II in physiological fluids and tissues: II. Extraction and quantification in rat tissues. Endocrinol. 128:815-822.
30. Miell, J. P., C. R. Buchanan, M. R. Norman, H. G. Maheshwari, and W. F. Blum. 1994. The evolution of changes in immunoreactive serum insulin-like growth factors (IGFs), IGF-binding proteins, circulating growth hormone (GH) and GH-binding protein as a result of short-term dexamelhasone treatment. J. Endocr. 142:547-554.
31. Frystyk, J., C. Skjærbæk, B. Dinesen, and H. Orskov. 1994. Free insulin-like growth factors (IGF-I and IGF-II) in human serum. FEBS Lett. 348:185-191.
32. Bang, P., K. Brismar, R.G. Rosenfeld, and K. Hall. 1994. Fasting affects serum insulin-like growth factors (IGFs) and IGF-binding proteins differently in patients with noninsulin-dependent diabetes mellitus versus healthy nonobese and obese subjects. J. Clin. Endocrinol. Metab. 78:960-967.
33. Davenport, M. L., M. E. Svoboda, K. L. Koerber, J. J. Van Wyk, D. R. Clemmons, and L. E. Underwood. 1988. Serum concentrations of insulin-like growth factor II are not changed by short term fasting and refeeding. J. Clin. Endocrinol. Metab. 67:1231-1236.
34. Bornfeldt, K. E., H. J. Arnqvist, B. Enberg, L. S. Mathews, and G. Norstedt. 1989. Regulation of insulin-like growth factor-I and growth hormone receptor gene expression by diabetes and nutritional state in rat tissues. J. Endocrinol. 122:651-656.
35. VandeHaar, M. J., B. M. Moats-Staats, M. L. Davenport, J. L. Walker, J. Ketelslegers, B. K. Sharma, and L. E. Underwood. 1991. Reduced serum concentrations of insulin-like growth factor-I (IGF-I) in protein-restricted growing rats are accompanied by reduced IGF-I mRNA levels in liver and skeletal muscle. J. Endocrinol. 130:305-312.
36. Hamilton, M. T., D. R. Marsh, D. S. Criswell, W. Lou, and F. W. Booth. 1995. No effect of aging on skeletal muscle insulin-like growth factor mRNAs. Am. J. Physiol. 269:R1183-R1188.
37. Stassijns, G., G. Gayan-Ramirez, P. De Leyn, R. Lysens, and M. Decramer. 1997. Effects of congestive heart failure (CHF) on diaphragm in rats (abstract). Am. J. Respir. Crit. Care Med. 155:A509.
38. Gayan-Ramirez, G., M. Van de Casteele, H. Rollier, J. Fevery, F. Vanderhoydonc, G. Verhoeven, and M. Decramer. 1997. Biliary cirrhosis decreases IGF-I mRNA in the liver but not in muscles in rats (abstract). Am. J. Respir. Crit. Care Med. 155:A509.
39. Douglass, J. A., D. V. Tuxen, M. Horne, C. D. Scheinkestel, M. Weinmann, D. Czarny, and G. Bowes. 1992. Myopathy in severe asthma. Am. Rev. Respir. Dis. 146:517-519.
40. Leatherman, J. W., W. L. Fluegel, W. S. David, S. F. Davies, and C. Iber. 1996. Muscle weakness in mechanically ventilated patients with severe asthma. Am. J. Respir. Crit. Care Med. 153:1686-1690.